PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D825F22G1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $10,448
Award facts
- Contract value 100% obligated
- $10,447.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,447.93 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 11, 2025. This firm fixed-price delivery order, which represents a non-set-aside competitive award, is scheduled for completion by August 12, 2025, with performance executed from the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with the DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This master contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceuticals and medical supplies to support military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant portfolio of federal medical procurement contracts with the Defense Logistics Agency. The company's federal contract awards demonstrate capability in delivering diverse pharmaceutical products and medical supplies including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. All reviewed contract awards were competitively awarded, indicating the contractor's ability to meet federal procurement standards through open competition. The DLA Medical Supply Chain plans to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple awards for separate regions, positioning AmerisourceBergen to continue serving defense and veteran healthcare systems through this flexible contract vehicle.
Quick answers
Who was awarded contract SPE2D825F22G1?
SPE2D825F22G1 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on August 11, 2025.
How much is contract SPE2D825F22G1 worth?
The government has obligated $10,448 on SPE2D825F22G1.
Is contract SPE2D825F22G1 an order under another contract?
Yes. SPE2D825F22G1 is a delivery order under SPE2DX22D0069, an indefinite delivery contract.
Was contract SPE2D825F22G1 competed?
The extent of competition for SPE2D825F22G1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award